1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Synthetic lethality: Achilles heel in select patient subpopulations
    Book Section

    Teo, M. Y.; O'Reilly, E. M.
    In Bekaii-Saab, T.; El-Rayes, B. (Eds.) Current and Emerging Therapies in Pancreatic Cancer (2018)

    Fulltext@MSK | Save
  • Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma
    Journal Article

    Pianko, M. J.; Funt, S. A.; Page, D. B.; Cattry, D.; Scott, E. C.; Ansell, S. M.; Borrello, I. M.; Gutierrez, M.; Lendvai, N.; Hassoun, H.; more...
    Leukemia and Lymphoma (2018)

    Fulltext@MSK | Save
  • Genomic alterations and outcomes with VEGF-targeted therapy in patients with clear cell renal cell carcinoma
    Journal Article

    Carlo, M. I.; Manley, B.; Patil, S.; Woo, K. M.; Coskey, D. T.; Redzematovic, A.; Arcila, M.; Ladanyi, M.; Lee, W.; Chen, Y. B.; more...
    Kidney Cancer (2017)

    Fulltext@MSK | Save
  • PTEN loss-of-function alterations are associated with intrinsic resistance to BRAF inhibitors in metastatic melanoma
    Journal Article

    Catalanotti, F.; Cheng, D. T.; Shoushtari, A. N.; Johnson, D. B.; Panageas, K. S.; Momtaz, P.; Higham, C.; Won, H. H.; Harding, J. J.; Merghoub, T.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • The hematopoietic cell transplantation comorbidity index (HCT-CI) is not predictive of outcomes in germ CE cancer patients receiving autologous transplantation
    Meeting Abstract

    Greenberg, D.; Shah, G. L.; Maloy, M.; Devlin, S. M.; Giralt, S. A.; Perales, M. A.; Feldman, D. R.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
    Journal Article

    Abida, W.; Armenia, J.; Gopalan, A.; Brennan, R.; Walsh, M.; Barron, D.; Danila, D.; Rathkopf, D.; Morris, M.; Slovin, S.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • OncoKB: A precision oncology knowledge base
    Journal Article

    Chakravarty, D.; Gao, J.; Phillips, S.; Kundra, R.; Zhang, H.; Wang, J.; Rudolph, J. E.; Yaeger, R.; Soumerai, T.; Nissan, M. H.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • Efficacy, safety, and immune activation with pegylated human IL-10 (AM0010) in combination with an anti-PD1 in advanced NSCLC
    Meeting Abstract

    Wong, D. J. L.; Schneider, J. G.; Aljumaily, R.; Korn, W. M.; Infante, J. R.; Patel, M. R.; Autio, K. A.; Papadopoulos, K. P.; Naing, A.; Gabrail, N. Y.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • The immunomodulatory protein Dickkopf-1 (DKK1) defines a non-neuroendocrine subtype of metastatic castration-resistant prostate cancer (mCRPC) with low AR and low PSA expression
    Meeting Abstract

    Wise, D.; Armenia, J.; Chen, Y.; Nelson, P.; Schultz, N.; Sawyers, C. L.; Scher, H. I.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Integrated biomarker analysis for 412 renal cell cancer (RCC) patients (pts) treated on the phase 3 COMPARZ trial: Correlating common mutation events in PBRM1 and BAP1 with angiogenesis expression signatures and outcomes on tyrosine kinase inhibitor (TKI) therapy
    Meeting Abstract

    Voss, M. H.; Kuo, F.; Chen, D.; Marker, M.; Patel, P.; Redzematovic, A.; Riaz, N.; Chan, T. A.; Choueiri, T. K.; Hsieh, J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save